In Wake of Dispute with Ariadne, Stratagene Inks Bioinformatics Software Deal with Strand | GenomeWeb

Following a dispute with bioinformatics partner Ariadne, Stratagene said last week that it would collaborate with Strand Life Sciences to develop bioinformatics software to analyze biological pathways and Affymetrix's new GeneChip microarrays.

Terms of the agreement call for the companies to co-design and co-develop software based on Strand's Avadis technology. Stratagene will exclusively market and sell the two products "shortly," the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.